Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial

Several lines of emerging data point to an imbalance between neuronal excitation and inhibition in at least a subgroup of individuals with autism spectrum disorder (ASD), including in those with fragile X syndrome (FXS), one of the most common genetic syndromes within ASD. In animal models of FXS an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropsychopharmacology
Autors principals: Veenstra-VanderWeele, Jeremy, Cook, Edwin H, King, Bryan H, Zarevics, Peter, Cherubini, Maryann, Walton-Bowen, Karen, Bear, Mark F, Wang, Paul P, Carpenter, Randall L
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436109/
https://ncbi.nlm.nih.gov/pubmed/27748740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2016.237
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars